ipilimumab,nivolumab
bms
['/ipi', 'nivo']
#asco22 median os 14.7m with nivo/ipi vs 9.9 chemo (hr 00.85, p=0.3). os worse with nivo/ipi in ps2. os better with nivo/ipi in older pts with ps 0-1. clear and impactful results here - age should not be reason to withhold io but ps should. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him